Modeling SNP mediated differential targeting of homologous 3′UTR by microRNA

RNA Biology

Volumn 9, Issue 3, 2012, Pages 351-360

  Ahluwalia, Jasmine Kaur ^a,b   Soni, Kartik ^b   Sivasubbu, Sridhar ^b   Brahmachari, Vani ^a  

^a UNIVERSITY OF DELHI   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Differential regulation of homologous alleles; Incomplete penetrance; JAG1; MicroRNA; TGFBR2; Variable expressivity

Indexed keywords

JAGGED1; LUCIFERASE; MICRORNA;

3' UNTRANSLATED REGION; ALAGILLE SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; DIPLOIDY; DOMINANT INHERITANCE; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; GENE TARGETING; GENETIC REGULATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PENETRANCE; PROTEIN RNA BINDING; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860758067     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.19318     Document Type: Article

References (28)

1. Van Heyningen V, Yeyati PL. Mechanisms of non- Mendelian inheritance in genetic disease. Hum Mol Genet 2004; 13(SpecNo 2):R225-33; PMID:15358729; http://dx.doi.org/10.1093/hmg/ddh254
2. Harder A, Titze S, Herbst L, Harder T, Guse K, Tinschert S, et al. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5′ untranslated region, exon and intron 1. Twin Res Hum Genet 2010; 13:582-94; PMID:21142935; http://dx.doi.org/10.1375/twin.13.6.582
3. Di Pierro E, Brancaleoni V, Moriondo V, Besana V, Cappellini MD. Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria. Clin Genet 2007; 71:84-8; PMID:17204051; http://dx.doi.org/10.1111/j.1399-0004.2007.00733.x
4. Gouya L, Puy H, Robreau AM, Bourgeois M, Lamoril J, Da Silva V, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 2002; 30:27-8; PMID:11753383; http://dx.doi.org/10.1038/ng809
5. Poelzing S, Forleo C, Samodell M, Dudash L, Sorrentino S, Anaclerio M, et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 2006; 114: 368-76; PMID:16864729; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.601294
6. Rivolta C, McGee TL, Rio Frio T, Jensen RV, Berson EL, Dryja TP. Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations. Hum Mutat 2006; 27:644-53; PMID: 16708387; http://dx.doi.org/10.1002/humu.20325
7. Vithana EN, Abu-Safieh L, Pelosini L, Winchester E, Hornan D, Bird AC, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci 2003; 44:4204-9; PMID:14507862; http://dx.doi.org/10.1167/iovs.03-0253
8. Zakharova IS, Shevchenko AI, Zakian SM. Monoallelic gene expression in mammals. Chromosoma 2009; 118: 279-90; PMID:19242715; http://dx.doi.org/10.1007/ s00412-009-0206-8
9. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cisacting mechanisms regulating gene expression. PLoS Genet 2008; 4:e1000006; PMID:18454203; http://dx.doi.org/10.1371/journal. pgen.1000006
10. Ahluwalia JK, Hariharan M, Bargaje R, Pillai B, Brahmachari V. Incomplete penetrance and variable expressivity: is there a microRNA connection? Bioessays 2009; 31:981-92; PMID:19642110; http://dx.doi.org/10.1002/bies.200900066
11. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 2008; 68:8535-40; PMID:18922928; http://dx.doi.org/10.1158/0008-5472.CAN-08-2129
12. Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, et al. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011; 71:5175-81; PMID:21676885; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-4407
13. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 2010; 70:2789-98; PMID:20332227; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-3541
14. Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 2009; 69:7459-65; PMID:19738052; http://dx.doi.org/10.1158/0008-5472.CAN-09-1201
15. Kim J, Bartel DP. Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol 2009; 27:472-7; PMID:19396161; http://dx.doi.org/10.1038/nbt.1540
16. Hariharan M, Scaria V, Brahmachari SK. dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 2009; 10:108; PMID:19371411; http://dx.doi.org/10.1186/1471-2105-10-108
17. Spinner NB, Colliton RP, Crosnier C, Krantz ID, HadchouelM,Meunier- Rotival M. Jagged1 mutations in alagille syndrome. Hum Mutat 2001; 17:18-33; PMID: 11139239; http://dx.doi.org/10.1002/1098-1004(2001)17:1<18::AID- HUMU3>3.0.CO;2-T
18. Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet 1997; 34:152-7; PMID:9039994; http://dx.doi.org/10.1136/jmg.34.2.152
19. Elmslie FV, Vivian AJ, Gardiner H, Hall C, Mowat AP, Winter RM. Alagille syndrome: family studies. J Med Genet 1995; 32:264-8; PMID:7643353; http://dx.doi.org/10.1136/jmg.32.4.264
20. Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G, et al. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 1998; 82:474-9; PMID:9723636; http://dx.doi.org/10.1016/S0002-9149(98)00364-6
21. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002; 129:1075-82;PMID:11861489
22. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310:317-20; PMID:16224024; http://dx.doi.org/10.1126/science.1116502
23. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006; 38:813-8; PMID: 16751773; http://dx.doi.org/10.1038/ng1810
24. Hasstedt SJ, Leppert M, Filloux F, van de Wetering BJ, McMahon WM. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet 1995; 57:682-9; PMID:7668298
25. Comings DE, Comings BG, Devor EJ, Cloninger CR. Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet 1984; 36:586-600; PMID: 6587774
26. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010; 107: 13450-5; PMID:20624982; http://dx.doi.org/10.1073/pnas.1002120107
27. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007; 104:3300-5; PMID:17360642; http://dx.doi.org/10.1073/pnas.0611347104
28. Chen K, Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 2006; 38:1452-6; PMID:17072316; http://dx.doi.org/10.1038/ng1910